Prophylaxis against respiratory syncytial virus in premature infants

Publisher Website

1 September 1999

journal article
Published by Elsevier in The Lancet

Vol. 354 (9183) , 1003-1004
https://doi.org/10.1016/s0140-6736(99)02368-5

Abstract

No abstract available

Keywords

This publication has 2 references indexed in Scilit:

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
Pediatrics, 1998
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection
The Journal of Pediatrics, 1995